The UNC Blood Research Center is committed to supporting the advancement of medical knowledge about bleeding and clotting disorders by supporting clinical and laboratory research in these areas. We are fortunate to be part of the University of North Carolina at Chapel Hill and its extensive network of research support services.
To view individual investigator webpages and learn more about specific researchers, please visit our Investigators page
Our research portfolio encompasses many aspects of hemostasis and thrombosis. These include, but are not limited to: hemophilia A and B (gene therapy, new types of prophylaxis for hemophilia patients, drug comparisons, etc.), pulmonary embolism (PE), deep vein thrombosis (DVT), venous thromboembolism (VTE), myeloproliferative neoplasms (MPN), cancer related thrombosis, hemophilia joint issues, hemophilic arthropathy pain management, von Willebrand disease as well as Sickle Cell Disease.
Research opportunities are offered to our clinic patients on a regular basis. To learn more about our research program or general research inquiries can be sent to: email@example.com.
Sickle Cell Disease Research contact firstname.lastname@example.org
Clinical Trials Team